271 related articles for article (PubMed ID: 14768953)
41. Some patients with antiphospholipid syndrome express hitherto undescribed antibodies to cardiolipin-binding proteins.
Rampazzo P; Biasiolo A; Garin J; Rosato A; Betterle C; Ruffatti A; Pengo V
Thromb Haemost; 2001 Jan; 85(1):57-62. PubMed ID: 11204589
[TBL] [Abstract][Full Text] [Related]
42. Involvement of TLR4 in oxidized LDL/β2GPI/anti-β2GPI-induced transformation of macrophages to foam cells.
Zhang X; Xie Y; Zhou H; Xu Y; Liu J; Xie H; Yan J
J Atheroscler Thromb; 2014; 21(11):1140-51. PubMed ID: 24998486
[TBL] [Abstract][Full Text] [Related]
43. Recombinant domain V of β2-glycoprotein I inhibits the formation of atherogenic oxLDL/β2-glycoprotein I complexes.
Li J; Chi Y; Liu S; Wang L; Wang R; Han X; Matsuura E; Liu Q
J Clin Immunol; 2014 Aug; 34(6):669-76. PubMed ID: 24970589
[TBL] [Abstract][Full Text] [Related]
44. Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies.
Metzger J; von Landenberg P; Kehrel M; Buhl A; Lackner KJ; Luppa PB
Clin Chem; 2007 Jun; 53(6):1137-43. PubMed ID: 17434906
[TBL] [Abstract][Full Text] [Related]
45. {beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome.
Sikara MP; Routsias JG; Samiotaki M; Panayotou G; Moutsopoulos HM; Vlachoyiannopoulos PG
Blood; 2010 Jan; 115(3):713-23. PubMed ID: 19805618
[TBL] [Abstract][Full Text] [Related]
46. The BH1 idiotype defines a population of anticardiolipin antibodies closely associated with the antiphospholipid syndrome.
Mason AN; Harmer IJ; Mageed RA; Mackworth-Young CG
Lupus; 1999; 8(3):234-9. PubMed ID: 10342717
[TBL] [Abstract][Full Text] [Related]
47. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome.
Blank M; Krause I; Fridkin M; Keller N; Kopolovic J; Goldberg I; Tobar A; Shoenfeld Y
J Clin Invest; 2002 Mar; 109(6):797-804. PubMed ID: 11901188
[TBL] [Abstract][Full Text] [Related]
48. Autoimmune-mediated atherothrombosis.
Matsuura E; Lopez LR
Lupus; 2008 Oct; 17(10):878-87. PubMed ID: 18827052
[TBL] [Abstract][Full Text] [Related]
49. Laboratory Evaluation of Antiphospholipid Syndrome.
Heikal N; Martins TB; White SK; Willis R; Ware Branch D; Schmidt RL; Tebo AE
Am J Clin Pathol; 2019 Oct; 152(5):638-646. PubMed ID: 31305881
[TBL] [Abstract][Full Text] [Related]
50. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
[TBL] [Abstract][Full Text] [Related]
51. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
[TBL] [Abstract][Full Text] [Related]
52. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
53. Atherosclerosis in autoimmune diseases.
Matsuura E; Kobayashi K; Lopez LR
Curr Rheumatol Rep; 2009 Feb; 11(1):61-9. PubMed ID: 19171113
[TBL] [Abstract][Full Text] [Related]
54. OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patients.
Bassi N; Ghirardello A; Iaccarino L; Zampieri S; Rampudda ME; Atzeni F; Sarzi-Puttini P; Shoenfeld Y; Doria A
Autoimmun Rev; 2007 Nov; 7(1):52-58. PubMed ID: 17967726
[TBL] [Abstract][Full Text] [Related]
55. Oxidation of beta2-glycoprotein I (beta2GPI) by the hydroxyl radical alters phospholipid binding and modulates recognition by anti-beta2GPI autoantibodies.
Arvieux J; Regnault V; Hachulla E; Darnige L; Berthou F; Youinou P
Thromb Haemost; 2001 Oct; 86(4):1070-6. PubMed ID: 11686326
[TBL] [Abstract][Full Text] [Related]
56. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
von Scheven E; Glidden DV; Elder ME
Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
[TBL] [Abstract][Full Text] [Related]
57. Anti-β2GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in China.
Zhou Y; Hu C; Qi W; Long Y; Huang C; Wang Q; Tian X; Zhao J; Li M; Zeng X
Lupus Sci Med; 2023 Aug; 10(2):. PubMed ID: 37607781
[TBL] [Abstract][Full Text] [Related]
58. Anti-beta 2-glycoprotein I autoantibodies from patients with the "antiphospholipid" syndrome bind to beta 2-glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody affinity.
Sheng Y; Kandiah DA; Krilis SA
J Immunol; 1998 Aug; 161(4):2038-43. PubMed ID: 9712077
[TBL] [Abstract][Full Text] [Related]
59. Low prevalence of antiannexin A5 antibodies in unprovoked venous thrombosis.
Ho WK; Rigano J
Int J Lab Hematol; 2021 Oct; 43(5):1225-1228. PubMed ID: 33586909
[TBL] [Abstract][Full Text] [Related]
60. oxLDL/beta2GPI complex and anti-oxLDL/beta2GPI in SLE: prevalence and correlates.
Bassi N; Zampieri S; Ghirardello A; Tonon M; Zen M; Beggio S; Matsuura E; Doria A
Autoimmunity; 2009 May; 42(4):289-91. PubMed ID: 19811279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
